Your browser doesn't support javascript.
loading
The therapeutic potential of thiocyanate and hypothiocyanous acid against pulmonary infections.
Ashtiwi, Nuha Milad; Kim, Susan O; Chandler, Joshua D; Rada, Balázs.
Afiliação
  • Ashtiwi NM; Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.
  • Kim SO; Pediatrics, Division of Pulmonary, Allergy & Immunology, Cystic Fibrosis, and Sleep Medicine, Emory University, Atlanta, GA, USA.
  • Chandler JD; Pediatrics, Division of Pulmonary, Allergy & Immunology, Cystic Fibrosis, and Sleep Medicine, Emory University, Atlanta, GA, USA; Children's Healthcare of Atlanta, Atlanta, GA, USA.
  • Rada B; Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, USA. Electronic address: radab@uga.edu.
Free Radic Biol Med ; 219: 104-111, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38608822
ABSTRACT
Hypothiocyanous acid (HOSCN) is an endogenous oxidant produced by peroxidase oxidation of thiocyanate (SCN-), an ubiquitous sulfur-containing pseudohalide synthesized from cyanide. HOSCN serves as a potent microbicidal agent against pathogenic bacteria, viruses, and fungi, functioning through thiol-targeting mechanisms, independent of currently approved antimicrobials. Additionally, SCN- reacts with hypochlorous acid (HOCl), a highly reactive oxidant produced by myeloperoxidase (MPO) at sites of inflammation, also producing HOSCN. This imparts both antioxidant and antimicrobial potential to SCN-. In this review, we discuss roles of HOSCN/SCN- in immunity and potential therapeutic implications for combating infections.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiocianatos / Anti-Infecciosos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiocianatos / Anti-Infecciosos Idioma: En Ano de publicação: 2024 Tipo de documento: Article